TOP 10 COMPANIES IN MICROFLUDIC IMMUNOASSAY MARKET
|
The global Microfluidic Immunoassay Market is anticipated to achieve a valuation of $1.47 billion by 2030, with a
compound annual growth rate (CAGR) of 7.4% during the forecast period,
according to a report by Meticulous Research®. Microfluidic immunoassays,
utilizing lab-on-chip microfluidic platforms, have emerged as pivotal tools
for diagnostic and research applications, particularly in point-of-care
testing.
The applications of
microfluidic immunoassays span across cardiology, oncology, infectious
diseases, diabetes, and various other domains. The market's growth is fueled
by increased adoption in drug discovery and biomarker detection, coupled with
the advantages of lab-on-chip immunoassays over conventional methods. However,
challenges like bubble formation and dead volume in microfluidic devices
hinder the market's expansion.
Key Market
Drivers:
- Increased
Utilization in Drug Discovery & Development:
The escalating use of microfluidic immunoassays in drug development and
biomarker detection is a primary driver.
- Advantages Over
Conventional Methods: Lab-on-chip
immunoassays offer distinct advantages over conventional immunoassays,
contributing to their growing adoption.
- Research &
Development Focus: Pharmaceutical and
biotechnology companies are intensifying their research and development
efforts, boosting the demand for microfluidic immunoassays.
- Miniaturization
of Assays: The trend towards miniaturization of
biological and chemical assays is a key factor in the market's evolution.
Market
Challenges:
- Bubble Formation
and Dead Volume: Challenges
associated with bubble formation and dead volume in microfluidic devices
present obstacles to market growth.
- Material
Selection for Microfluidic Chips: Choosing suitable
substrate materials for designing microfluidic chips remains a challenge
for industry stakeholders.
- Cost-Related
Limitations in Developing Countries: Product design and
cost-related limitations in developing countries pose challenges to
market stakeholders.
Market Growth
Opportunities:
- Rising Demand for
Point-of-Care Diagnostics: The increasing
demand for point-of-care diagnostics is expected to fuel market growth.
- Technological
Advancements: Recent advancements in microfluidic
immunoassay technology are creating new market opportunities.
Top 10 Companies Dominating
the Microfluidic Immunoassay Market: https://meticulousblog.org/top-10-companies-in-microfluidic-immunoassay-market/
Key Market Players
The report identifies the top 10
companies leading the Microfluidic Immunoassay Market:
1.
Abbott Laboratories (U.S.): A global healthcare
product leader with a diverse portfolio.
2.
Revvity, Inc. (U.S.) (Formerly
PerkinElmer, Inc.): A multinational offering life science and diagnostic
solutions.
3.
Siemens Healthineers AG
(Germany): Providing innovative healthcare solutions and services
globally.
4.
QuidelOrtho Corporation (U.S.): Specializing in
diagnostic solutions through point-of-care testing.
5.
Nanomix, Inc. (U.S.): A company focused on
analytical detection devices for point-of-care diagnostics.
6.
Becton, Dickinson and Company
(U.S.): A medical technology firm offering a range of medical devices
and diagnostic products.
7.
Micropoint Biotechnologies
Co., Ltd. (China): Providing rapid point-of-care diagnostic products.
8.
Biosurfit SA (Portugal): A diagnostics
company focused on in-vitro diagnostic tests for point-of-care applications.
9.
Koninklijke Philips N.V.
(Netherlands): A leader in developing and distributing diagnosis and
treatment solutions.
10.
NanoEnTek Inc. (South Korea): Specializing in life
science experiment equipment and medical in-vitro diagnostic devices.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5034
About
Meticulous Research®:
Meticulous Research®, in
its latest report on the Microfluidic Immunoassay Market, projects a growth
rate of 7.4% during the forecast period from 2023 to 2030. The comprehensive
report provides detailed insights into the financial performance, key products,
company strategies, partnerships, and acquisitions of each of the mentioned
companies. Additionally, it covers global market size estimates, market share
analysis, revenue figures, and addresses key industry trends.
For more information, please refer to
Meticulous Research®’s comprehensive report on the Microfluidic Immunoassay
Market - "Global Opportunity Analysis and Industry Forecast
(2023-2030)."
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
|
Comments
Post a Comment